8-K: InnovAge Soars: Q1 FY26 Revenue Jumps 15% with Profit Turnaround

InnovAge Holding Corp. announced a strong start to fiscal 2026, reporting a significant increase in revenue and a return to profitability for its first quarter ended September 30, 2025.

Summary

• Total revenues for the first fiscal quarter ended September 30, 2025, reached $236.1 million, an increase of approximately 15.1% compared to $205.1 million in the prior year.
• The company reported Income Before Income Taxes of $7.9 million, a substantial improvement from a Loss Before Income Taxes of $5.3 million in the first quarter of fiscal year 2025.
• Net income was $7.7 million, compared to a net loss of $5.7 million in the same period last year, with net income attributable to InnovAge Holding Corp. at $8.0 million, or $0.06 per share.
• Center-level Contribution Margin increased by 48.7% to $51.4 million, representing 21.8% of revenue, up from 16.8% in the prior year.
• Adjusted EBITDA grew by $11.2 million to $17.6 million, achieving a margin of 7.5%, a significant increase from 3.2% in the first quarter of fiscal year 2025.
• Participant census grew to approximately 7,890, up from 7,210 participants in the first quarter of fiscal year 2025.
• InnovAge ended the quarter with $67.1 million in cash and cash equivalents, $42.3 million in short-term investments, and $71.5 million in debt.
• The company confirmed its full fiscal year 2026 financial guidance, projecting total revenues between $900 million and $950 million, and Adjusted EBITDA between $56 million and $65 million.

Sentiment

Score: 9

Explanation: The filing indicates a very strong positive sentiment due to a significant financial turnaround from loss to profit, substantial revenue and EBITDA growth, and increased participant enrollment, all while confirming positive future guidance.

Positives

• Significant revenue growth of 15.1% to $236.1 million, indicating strong business momentum.
• Turnaround from a net loss of $5.7 million to a net income of $7.7 million, demonstrating improved operational efficiency and financial health.
• Substantial increase in Income Before Income Taxes by 249.2% to $7.9 million.
• Robust growth in Center-level Contribution Margin by 48.7% to $51.4 million, reflecting better core operating performance.
• Adjusted EBITDA more than doubled, increasing by $11.2 million to $17.6 million, with a significant margin expansion to 7.5%.
• Consistent participant census growth, reaching 7,890, indicating successful enrollment and retention in the PACE program.
• Confirmation of full fiscal year 2026 financial guidance, providing stability and confidence in future performance.

Risks

• The viability of the growth strategy, including the ability to find suitable geographies for new centers, attract and retain participants, and obtain necessary licenses.
• Challenges in identifying, successfully completing, and integrating acquisitions, joint ventures, and other strategic partnerships.
• Impacts from ongoing macroeconomic challenges such as labor shortages, labor competition, inflation, tariffs, trade disputes, and potential government shutdowns.
• Risks associated with inspections, reviews, audits, and investigations under federal and state government programs, and the ability to cure identified deficiencies.
• Potential costs and distractions from legal proceedings, enforcement actions, litigation, and disputes.
• Assumption of full risk under PACE contracts where the cost of providing services may exceed compensation.
• Dependence of revenues on a limited number of government payors, with the risk of sudden loss of any government contracts.
• Impact of state and federal efforts to reduce healthcare spending, including recent legislation affecting Medicaid funding.
• Risk of inaccurate or unsupportable information in submissions to government payors, potentially leading to repayment obligations or penalties.
• The ability to comply with the continued listing requirements of Nasdaq.

Future Outlook

InnovAge confirmed its full fiscal year 2026 financial guidance, projecting a participant census between 7,900 and 8,100, total member months between 91,600 and 94,400, total revenues between $900 million and $950 million, and Adjusted EBITDA between $56 million and $65 million. The company remains focused on delivering high-quality, cost-effective care to more seniors and building a foundation for sustainable growth.

Management Comments

• "We're off to a strong start in fiscal 2026," said Patrick Blair, CEO.
• "Our results reflect disciplined execution, continued investment in our people and technology, and growing momentum in the business."
• "We remain focused on delivering high-quality, cost-effective care to more seniors while building the foundation for sustainable growth."

Industry Context

InnovAge operates as a market leader in the Program of All-inclusive Care for the Elderly (PACE), providing comprehensive healthcare to frail, predominantly dual-eligible seniors. This model aligns with broader healthcare industry trends emphasizing value-based care, integrated services, and enabling older adults to age independently at home, aiming to improve care quality and reduce the utilization of high-cost care settings. The company's growth in participant census and improved financial performance suggest effective execution within this specialized and growing segment of healthcare.

Comparison to Industry Standards

• NA

Legal Proceedings

• The company acknowledges risks related to litigation by stockholders, civil investigative demands, and arbitration with a former pharmacy provider, with associated costs reflected in non-GAAP adjustments.

Stakeholder Impact

• Shareholders are positively impacted by the significant turnaround in profitability, strong revenue growth, and increased earnings per share.
• Participants benefit from the company's continued focus on delivering high-quality, cost-effective care through the PACE model.
• Government payors may see continued benefits from the PACE model's design to reduce over-utilization of high-cost care settings.

Next Steps

• InnovAge will host a conference call on November 4, 2025, at 5:00 PM Eastern Time to discuss the results.
• The company plans to continue investing in its people and technology to support sustainable growth.
• Management will remain focused on delivering high-quality, cost-effective care to more seniors.

Key Dates

Recommendation

InnovAge has demonstrated a remarkable financial turnaround, moving from a net loss to significant profitability in Q1 FY26, coupled with robust revenue and Adjusted EBITDA growth. The increase in participant census and the confirmation of positive full-year guidance underscore strong operational execution and a clear growth trajectory. These results suggest the company is effectively executing its strategy in a critical healthcare segment, making it an attractive investment.

Keywords

InnovAge, INNV, PACE, healthcare, elderly care, financial results, Q1 2026, revenue, net income, EBITDA, participant census, financial guidance, SEC filing